201 related articles for article (PubMed ID: 35700727)
21. Characteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression.
Perland E; Bagchi S; Klaesson A; Fredriksson R
Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878041
[TBL] [Abstract][Full Text] [Related]
22. Role of solute carrier transporters in regulating dendritic cell maturation and function.
Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
[TBL] [Abstract][Full Text] [Related]
23. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
24. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
25. Analysis and update of the human solute carrier (SLC) gene superfamily.
He L; Vasiliou K; Nebert DW
Hum Genomics; 2009 Jan; 3(2):195-206. PubMed ID: 19164095
[TBL] [Abstract][Full Text] [Related]
26. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
[TBL] [Abstract][Full Text] [Related]
27. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction.
Hediger MA; Romero MF; Peng JB; Rolfs A; Takanaga H; Bruford EA
Pflugers Arch; 2004 Feb; 447(5):465-8. PubMed ID: 14624363
[TBL] [Abstract][Full Text] [Related]
28. Solute carriers (SLCs) identified and characterized from kidney transcriptome of golden mahseer (Tor putitora) (Fam: Cyprinidae).
Barat A; Sahoo PK; Kumar R; Pande V
Comp Biochem Physiol B Biochem Mol Biol; 2016 Oct; 200():54-61. PubMed ID: 27287540
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
Dvorak V; Superti-Furga G
Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
[TBL] [Abstract][Full Text] [Related]
30. Targeting solute carriers to modulate receptor-ligand interactions.
Sijben HJ; Superti-Furga G; IJzerman AP; Heitman LH
Trends Pharmacol Sci; 2022 May; 43(5):358-361. PubMed ID: 35232590
[TBL] [Abstract][Full Text] [Related]
31. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
32. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.
Fredriksson R; Nordström KJ; Stephansson O; Hägglund MG; Schiöth HB
FEBS Lett; 2008 Nov; 582(27):3811-6. PubMed ID: 18948099
[TBL] [Abstract][Full Text] [Related]
33. High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies.
Raturi S; Li H; Chang YN; Scacioc A; Bohstedt T; Fernandez-Cid A; Evans A; Abrusci P; Balakrishnan A; Pascoa TC; He D; Chi G; Kaur Singh N; Ye M; Li A; Shrestha L; Wang D; Williams EP; Burgess-Brown NA; Dürr KL; Puetter V; Ingles-Prieto A; Sauer DB
J Vis Exp; 2023 Sep; (199):. PubMed ID: 37843272
[TBL] [Abstract][Full Text] [Related]
34. Emerging roles of the solute carrier family in pancreatic cancer.
Wu Z; Xu J; Liang C; Meng Q; Hua J; Wang W; Zhang B; Liu J; Yu X; Shi S
Clin Transl Med; 2021 Mar; 11(3):e356. PubMed ID: 33783998
[TBL] [Abstract][Full Text] [Related]
35. Solute Carriers in the Blood-Brain Barier: Safety in Abundance.
Nałęcz KA
Neurochem Res; 2017 Mar; 42(3):795-809. PubMed ID: 27503090
[TBL] [Abstract][Full Text] [Related]
36. Defining solute carrier transporter signatures of murine immune cell subsets.
Aaes TL; Burgoa Cardás J; Ravichandran KS
Front Immunol; 2023; 14():1276196. PubMed ID: 38077407
[TBL] [Abstract][Full Text] [Related]
37. Classification Systems of Secondary Active Transporters.
Perland E; Fredriksson R
Trends Pharmacol Sci; 2017 Mar; 38(3):305-315. PubMed ID: 27939446
[TBL] [Abstract][Full Text] [Related]
38. Targeting Solute Carrier Transporters through Functional Mapping.
Colas C; Laine E
Trends Pharmacol Sci; 2021 Jan; 42(1):3-6. PubMed ID: 33234336
[TBL] [Abstract][Full Text] [Related]
39. ρ⁰ Cells Feature De-Ubiquitination of SLC Transporters and Increased Levels and Fluxes of Amino Acids.
Medina AB; Banaszczak M; Ni Y; Aretz I; Meierhofer D
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28425971
[TBL] [Abstract][Full Text] [Related]
40. SLC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
